Best Biopharma Outsourcing Companies in Australia
The 80 best Biopharma Outsourcing companies in Australia in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Biointelect.
- ResearchAndMarkets.com
- market.us
Our analysis of 100 Biopharma Outsourcing companies
$10.3b in tracked funding; 68% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Biopharma Outsourcing companies in Australia
| # | Company | Disclosed funding | Last round | Stage | Founder | Founded | Tech stack | Recent signals |
|---|---|---|---|---|---|---|---|---|
| 1 | Biointelect Market evaluation and strategy design for biopharma, medical device and IVD companies | $33M | 11 mo ago | Funding Raised | — | 2011 | WordPressMySQLSalesforce+27 | 1 job opening |
| 2 | IDT Australia IDT Australia Ltd produces, develops, and supplies pharmaceutical products. | $6M | 127 mo ago | Public | — | 1975 | WordPressMySQLPHP+18 | — |
| 3 | BioCina CDMO offering microbial expression systems-based biologics development and manufacturing services | $6M | 37 mo ago | Funding Raised | Ian Wisenberg Founder & CEO | 2018 | WordPressMySQLPHP+25 | 1 partnership |
| 4 | MindBio Therapeutics Provider of phase I & II clinical trial services for mental health diseases | $3M | 2 mo ago | Public | Justin Hanka Co-Founder & Executive Director (CNSX:MBIO) | 2021 | Cart FunctionalitySquarespace CommerceSquarespace+12 | 3 launchs |
| 5 | Snapsil Manufacturer of sustainable, portion-control packaging. | $2M | 166 mo ago | Seed | Brad Teys Founder | 2011 | — | — |
| 6 | Smart MCs Smart biomaterials and microfluidic solutions provider for bioproduction | $600K | 38 mo ago | Funding Raised | Lin Ding Co-Founder & CTO | 2022 | — | — |
| 7 | Lipa Contract manufacturer of dietary supplements and OTC pharmaceutical products | $144K | 82 mo ago | Funding Raised | — | 1995 | WordPress Block EditorWordPressMySQL+18 | — |
| 8 | Cyclotek Provider of imaging services for clinical development | — | 31 mo ago | Late Stage | — | 2001 | WordPressMySQLPHP+13 | 2 partnerships |
Top 12 Biopharma Outsourcing companies in Australia
#1
Public · Melbourne, Victoria · founded 2021 · 18 employees$3Mraised▾
Provider of phase I & II clinical trial services for mental health diseases
- Apr 2026Post IPO$987.9K
- May 2025Post IPO$66.6K
- Apr 2025Post IPO$1.4M
- Apr 2025Post IPO$111.7K
#2
Funding Raised · Brookvale, New South Wales · founded 2011 · 26 employees$32.9Mraised▾
Biointelect offers market evaluation and strategy design and development services for biopharmaceutical, medical device, and IVD companies. While for early stage companies they provide product development support through their commercial and market insights, for late stage companies they offer services for product planning, project startup and development and also in identifying the right commercial partners. Base on their expertise in market evaluation, they help clients in designing their clinical, regulatory, reimbursement and market-entry strategies.
- Jul 2025Grant (prize money)$32.9M
#3
Funding Raised · Thebarton, South Australia · founded 2018 · 58 employees$5.6Mraised▾
CDMO offering microbial expression systems-based biologics development and manufacturing services
- Apr 2023Grant (prize money)$3.3M
- Apr 2022Grant (prize money)$2.3M
#4
Public · Australia · founded 1975 · 55 employees$6Mraised▾
IDT Australia Ltd produces, develops, and supplies pharmaceutical products. It is engaged in the provision of research and development and other technical services for the pharmaceutical and allied industries. The company is involved in the manufacture of Active Pharmaceutical Ingredients (API) and Finished Dose Forms (FDF), microbiological and analytical testing, clinical packaging, and pharmacy services.
#5
Funding Raised · Ultimo, New South Wales · founded 2022 · 2 employees$600Kraised▾
Smart biomaterials and microfluidic solutions provider for bioproduction. They specialize in creating customized biomaterials and microfluidic solutions tailored to specific cell types and applications. Their product suite includes microcarriers for efficient cell culture, hydrogels for tissue modeling and wound healing, and microfluidic platforms for various applications like cell sorting and droplet generation. These solutions are designed to streamline research and production processes in sectors such as stem cell therapeutics and cultivated meat production, aiming to improve efficiency and reduce waste. The company supports researchers and industry partners in scaling up cell production.
- Apr 2023Grant (prize money)$600K
#6
Seed · Sunshine Coast, Queensland · founded 2011 · 8 employees$1.9Mraised▾
{}
- Aug 2012Seed$1.3M
- Feb 2012Seed$600K
#7
Funding Raised · Minto, New South Wales · founded 1995 · 300 employees$144.4Kraised▾
Contract manufacturer of dietary supplements and OTC pharmaceutical products
- Aug 2019Grant (prize money)$118.9K
- Jun 2014Grant (prize money)$25.4K
#8
Late Stage · Bundoora, Victoria · founded 2001 · 72 employees—raised▾
Provider of imaging services for clinical development
- Nov 2023PE—
#9
Late Stage · Thebarton, South Australia · founded 2018 · 270 employees—raised▾
Provider of clinical development services
- Nov 2021PE—
#10
Acquired · Brunswick, Victoria · founded 1988 · 147 employees—raised▾
Provider of regulatory, clinical trials and analytic services
- Feb 2021Conventional Debt—
- Jun 2016PE—
#11
Series A · Cudgen, New South Wales · founded 2012—raised▾
Formative Health offers consulting services to biopharma and biotech industries. They offer consulting services for medical affairs, clinical development strategy and plan development, business strategy, and public health and training.
- Sep 2016Series A—
#12
Deadpooled · Perth, Western Australia · founded 2003 · 29 employees—raised▾
Provider of synthetic and medicinal chemistry services intended to enable the discovery and development of new drugs and ensure the quality of existing ones. The company's services include custom synthesis of analog libraries, scaffolds and intermediates, drug design, method development and reference standards of drug impurities, degradants and metabolites, enabling drug discovery and pharmaceutical companies to obtain quality pharmaceutical standards and discovery services.
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Biopharma Outsourcing coverage by sub-theme.
Regulatory-risk over time flat
Funding & growth over time
funding rising · growth rising
How research on Biotechnology is moving in Australia
A read on the academic research around Biotechnology — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 861 Australia-affiliated papers.
- University College London67
- The University of Queensland63
- The University of Melbourne59
- Agriculture and Food54
- La Trobe University35
- Mutant2→11
- Genome1→7
- Immune system1→5
- Antibody1→4
- Mitochondrion2→4
- Gene5→17
- Immune system2→13
- Antibody1→10
- Messenger RNA1→10
- Mutant1→9
- Agriculture5→19
- Sustainability3→8
- Emerging technologies1→4
- Resistance (ecology)3→6
- Bacteria2→5
Where biotechnology is researched across Australia
Location clusters by institution affiliation — each city's volume, stance tone, and a quick read on its hot topic, what's advancing, the opening opportunity, and the main concern.
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.